150 related articles for article (PubMed ID: 16083746)
1. Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum.
Brenner DJ; Hall EJ; Curtis RE; Ron E
Gastroenterology; 2005 Aug; 129(2):773-4; author reply 774-5. PubMed ID: 16083746
[No Abstract] [Full Text] [Related]
2. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
4. Risk of second malignancies after prostate irradiation?
Müller AC; Ganswindt U; Bamberg M; Belka C
Strahlenther Onkol; 2007 Nov; 183(11):605-9. PubMed ID: 17960335
[TBL] [Abstract][Full Text] [Related]
5. Commentary on the etiologic relationship between prostate radiation and bladder cancer: the scourge for one is poison for the other.
Konety BR
J Urol; 2008 May; 179(5 Suppl):S12-3. PubMed ID: 18405739
[No Abstract] [Full Text] [Related]
6. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.
Wallis CJ; Mahar AL; Choo R; Herschorn S; Kodama RT; Shah PS; Danjoux C; Narod SA; Nam RK
BMJ; 2016 Mar; 352():i851. PubMed ID: 26936410
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment.
Soloway MS
Urology; 2009 Oct; 74(4):871-2; author reply 872. PubMed ID: 19800511
[No Abstract] [Full Text] [Related]
9. Re: Conservative management of early bladder rupture after postoperative radiotherapy for prostate cancer.
Aherne NJ
Urol J; 2009; 6(2):145. PubMed ID: 19472138
[No Abstract] [Full Text] [Related]
10. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
Abdel-Wahab M; Reis IM; Hamilton K
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
[TBL] [Abstract][Full Text] [Related]
11. Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348).
Froehner M; Wirth MP
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279; author reply 1280. PubMed ID: 20542389
[No Abstract] [Full Text] [Related]
12. Rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer (Int J Radiat Oncol Biol Phys 2010;76:342-348).
Hyde C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1607; author reply 1607. PubMed ID: 20637987
[No Abstract] [Full Text] [Related]
13. Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.
Dörr W; Jaal J; Zips D
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():14-5. PubMed ID: 18166999
[No Abstract] [Full Text] [Related]
14. Lung carcinoma development after radiotherapy for breast carcinoma.
Buchholz TA
Cancer; 2003 Oct; 98(7):1331-3. PubMed ID: 14508817
[No Abstract] [Full Text] [Related]
15. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
Albertsen PC
J Urol; 2005 Nov; 174(5):1969-70. PubMed ID: 16217368
[No Abstract] [Full Text] [Related]
16. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O
J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.
Takam R; Bezak E; Yeoh EE
Phys Med Biol; 2009 Feb; 54(3):611-25. PubMed ID: 19124952
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
19. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
Klein EA; Ciezki J; Kupelian PA; Mahadevan A
Urol Oncol; 2009; 27(1):67-71. PubMed ID: 19111801
[TBL] [Abstract][Full Text] [Related]
20. A (relatively) risky business: the link between prostatic radiotherapy and second malignancies.
Eyler CE; Zietman AL
BMJ; 2016 Mar; 352():i1073. PubMed ID: 26935234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
